Contact Us
News

NeuroBo Pharmaceuticals Signs 2-Year Back Bay WeWork Lease

Want to get a jump-start on upcoming deals? Meet the major Boston players at one of our upcoming events!

NeuroBo Pharmaceuticals Signs 2-Year Back Bay WeWork Lease
200 Berkeley St.

A Boston-based pharmaceutical company focused on neurodegenerative disease treatment is providing a bright spot to WeWork’s uncertain Boston future

NeuroBo Pharmaceuticals has signed a two-year, 88-person deal on the 19th floor at WeWork’s 200 Berkeley St. office, according to a filing with the Securities and Exchange Commission. The $49,162.50 lease begins Dec. 2 and requires NeuroBo to pay WeWork a $98,325 service retainer ahead of moving in. The service retainer is a financial protection and is refunded at the end of a membership agreement, according to WeWork’s website. 

NeuroBo announced earlier this year plans to initiate the third phase of drug trials on its leading drug, NB-01, for patients with diabetic neuropathic pain. The pharmaceutical company also has NB-02, a neuroprotective drug targeting Alzheimer’s disease in its development pipeline.

The 10-person, full-time NeuroBo team currently works at Business District, a coworking space on the 17th floor at 177 Huntington Ave. NeuroBo will have private offices at WeWork, which is still under construction. While the company doesn’t need all 88 desks now, NeuroBo Executive Assistant Amy Breckenridge told Bisnow the company is moving to have space it can grow into. 

WeWork is also required to "use best efforts" to notify NeuroBo each time an office on the 19th floor becomes available, acccording to the membership agreement. The pharmaceutical company would have five business days to add the new space to its lease before WeWork would be able to lease the space to other companies. 

The 200 Berkeley office comes with access to internal conference space, which Breckenridge added is good for meetings with consultants in the growing company. NeuroBo announced a merger with Ann Arbor, Michigan-based Gemphire Therapeutics in July. The NeuroBo name will be used for the merged company.

WeWork has a more than 116K SF office at 200 Berkeley, according to Perry data. The 495-foot building, also known as the Old John Hancock Tower, is a Back Bay landmark with its rooftop weather beacon that provides weather forecasts with various blinking lights. 

The deal comes as Boston’s real estate community is widely speculating on the future of WeWork, Boston’s second-largest office tenant. Following its failed initial public offering and diminished valuation, two Boston landlords called off WeWork deals still in negotiation. The CEO of local competitor Workbar said she is taking calls from landlords about potentially taking over WeWork offices. 

While NeuroBo committed to the Back Bay WeWork four months ago, before the coworking giant’s financial issues became public, Breckenridge said NeuroBo is confident in its deal. 

“Everything is moving ahead as scheduled,” she said. “Things are looking good.”

A WeWork spokesperson declined to comment. 

Jarred Schenke contributed to this report.

Related Topics: WeWork, Back Bay, Workbar